NEOPLASM PROGRESSION

Adverse reaction reported in 24,346 FDA reports across 13 drugs.

24,346
Total Reports
13
Drugs Involved
Palbociclib
Most Reported Drug

Drugs Associated with NEOPLASM PROGRESSION

Drugs where "NEOPLASM PROGRESSION" was reported as an adverse event.

# Drug Reports % of Total
1 Palbociclib 10,620
43.6%
2 Letrozole 2,795
11.5%
3 Fulvestrant 2,128
8.7%
4 Sunitinib Malate 2,019
8.3%
5 Axitinib 1,323
5.4%
6 Crizotinib 1,112
4.6%
7 Everolimus 1,033
4.2%
8 Exemestane 924
3.8%
9 Vincristine 649
2.7%
10 Encorafenib 552
2.3%
11 Temozolomide 440
1.8%
12 Irinotecan 378
1.6%
13 Bosutinib 373
1.5%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. The presence of a drug in this list does not mean the drug caused neoplasm progression. Always consult your healthcare provider.